REVA Medical Inc - Product Pipeline Analysis, 2022 Update

Summary

REVA Medical Inc (REVA) is a medical device company that offers bioresorbable polymer technologies for vascular applications. The company offers solutions for patient health restoration through the application of biomaterials in the development and sale of implantable medical devices. It offers fantom, a bioresorbable vascular scaffold developed as an alternative to metallic stents for the treatment of coronary artery disease. It also develops proprietary polymers for scaffold performance. The company’s fantom supports the artery through the healing process providing restoration of blood flow. It operates in Australia, Brazil and New Zealand, among others. REVA is headquartered in San Diego, California, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company REVA Medical Inc
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company


REVA Medical Inc Company Overview
REVA Medical Inc Company Snapshot
REVA Medical Inc Pipeline Products and Ongoing Clinical Trials Overview
REVA Medical Inc – Pipeline Analysis Overview
REVA Medical Inc - Key Facts
REVA Medical Inc - Major Products and Services
REVA Medical Inc Pipeline Products by Development Stage
REVA Medical Inc Ongoing Clinical Trials by Trial Status
REVA Medical Inc Pipeline Products Overview
Fantom Sirolimus-Eluting Bioresorbable Coronary Scaffold
Fantom Sirolimus-Eluting Bioresorbable Coronary Scaffold Product Overview
Fantom Sirolimus-Eluting Bioresorbable Coronary Scaffold Clinical Trial
MOTIV Bioresorbable Scaffold
MOTIV Bioresorbable Scaffold Product Overview
MOTIV Bioresorbable Scaffold Clinical Trial
ReZolve Sirolimus-Eluting Bioresorbable Coronary Scaffold
ReZolve Sirolimus-Eluting Bioresorbable Coronary Scaffold Product Overview
ReZolve2 Drug Eluting Bioresorbable Coronary Scaffold
ReZolve2 Drug Eluting Bioresorbable Coronary Scaffold Product Overview
TYROSPHERE EMBOLIC BEAD
TYROSPHERE EMBOLIC BEAD Product Overview
REVA Medical Inc - Key Competitors
REVA Medical Inc - Key Employees
REVA Medical Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
REVA Medical Inc, Recent Developments
Aug 05, 2019: REVA receives additional interim funding
Mar 24, 2019: REVA receives interim funding commitment and announces leadership changes
Feb 05, 2019: REVA announces reduction in force
Jan 07, 2019: Reva expands geographic footprint to seven new countries
Jan 04, 2019: REVA Medical announces that Leigh Elkolli promoted to chief financial officer
Jan 03, 2019: Leigh Elkolli promoted to chief financial officer at Reva Medical
Dec 04, 2018: REVA announces first implant of the Fantom Encore Bioresorbable Scaffold in Italy
Nov 08, 2018: Reva Medical announces departure of Richard Kimes, SVP of operations
Nov 06, 2018: Reva Medical reports third quarter 2018 financial results
Oct 31, 2018: REVA announces commercial launch of the Fantom Encore Bioresorbable Scaffold
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
List of Tables
Table 1: REVA Medical Inc Pipeline Products and Ongoing Clinical Trials Overview
Table 2: REVA Medical Inc Pipeline Products by Equipment Type
Table 3: REVA Medical Inc Pipeline Products by Indication
Table 4: REVA Medical Inc, Key Facts
Table 5: REVA Medical Inc, Major Products and Services
Table 6: REVA Medical Inc Number of Pipeline Products by Development Stage
Table 7: REVA Medical Inc Pipeline Products Summary by Development Stage
Table 8: REVA Medical Inc Ongoing Clinical Trials by Trial Status
Table 9: REVA Medical Inc Ongoing Clinical Trials Summary
Table 10: Fantom Sirolimus-Eluting Bioresorbable Coronary Scaffold - Product Status
Table 11: Fantom Sirolimus-Eluting Bioresorbable Coronary Scaffold - Product Description
Table 12: Fantom Sirolimus-Eluting Bioresorbable Coronary Scaffold - Expanded FANTOM II Clinical Study
Table 13: Fantom Sirolimus-Eluting Bioresorbable Coronary Scaffold - Pilot Study of the REVA Sirolimus-Eluting Bioresorbable Coronary Scaffold
Table 14: Fantom Sirolimus-Eluting Bioresorbable Coronary Scaffold - Post Market Study of the FANTOM Sirolimus-eluting Bioresorbable Coronary Scaffold
Table 15: Fantom Sirolimus-Eluting Bioresorbable Coronary Scaffold - Safety and Efficacy of the FANTOM ENCORE Sirolimus-eluting Bioresorbable Scaffold for Treatment of De-novo Coronary Artery Disease: The ENCORE-I Study
Table 16: Fantom Sirolimus-Eluting Bioresorbable Coronary Scaffold - Safety and Performance Study of the FANTOM Sirolimus-eluting Bioresorbable Coronary Scaffold
Table 17: Fantom Sirolimus-Eluting Bioresorbable Coronary Scaffold - Vascular Healing Pattern, Vasoreactivity, and Quality of Life in Patients with ST Segment Elevation Myocardial Infarction Treated with Primary Percutaneous Coronary Intervention with Sirolimus Eluting FANTOM Bioresorbable Vascular Scaffold with Long Term Clinical, Near Infrared Spectroscopy and Optical Coherence Tomography Follow-up: A FANTOM STEMI Pilot Study
Table 18: MOTIV Bioresorbable Scaffold - Product Status
Table 19: MOTIV Bioresorbable Scaffold - Product Description
Table 20: MOTIV Bioresorbable Scaffold - A Prospective, Multicenter, Single Blind, Randomized Controlled Trial Evaluating the Safety and Effectiveness of the MOTIV Sirolimus-Eluting Bioresorbable Vascular Scaffold Compared With Plain Balloon Angioplasty for the Treatment of Infrapopliteal Lesions
Table 21: MOTIV Bioresorbable Scaffold - Physician-initiated Trial Investigating the MOTIV Bioresorbable Scaffold (Reva Medical) for the Treatment of Below-the-knee Artery Disease
Table 22: ReZolve Sirolimus-Eluting Bioresorbable Coronary Scaffold - Product Status
Table 23: ReZolve Sirolimus-Eluting Bioresorbable Coronary Scaffold - Product Description
Table 24: ReZolve2 Drug Eluting Bioresorbable Coronary Scaffold - Product Status
Table 25: ReZolve2 Drug Eluting Bioresorbable Coronary Scaffold - Product Description
Table 26: TYROSPHERE EMBOLIC BEAD - Product Status
Table 27: TYROSPHERE EMBOLIC BEAD - Product Description
Table 28: REVA Medical Inc, Key Employees
Table 29: REVA Medical Inc, Subsidiaries
Table 30: Glossary
List of Figures
Figure 1: REVA Medical Inc Pipeline Products by Equipment Type
Figure 2: REVA Medical Inc Pipeline Products by Development Stage
Figure 3: REVA Medical Inc Ongoing Clinical Trials by Trial Status

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings